HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heptelidic acid, a sesquiterpene lactone, inhibits Etoposide-induced apoptosis in human leukemia U937 cells.

Abstract
In the course of screening for substances that inhibit etoposide (10 microg/ml)-induced apoptosis in human leukemia U937 cells, fungal strain F000120, which exhibits potent inhibitory activity, was selected. The active compound was purified from an ethyl acetate extract of the microorganism by Sep-pak C18 column chromatography and HPLC, and was identified as heptelidic acid (koningic acid) by spectroscopic methods. This compound inhibited caspase- 3 induction in U937 cells with an IC(50) value of 40 microM after 8 h of etoposide treatment. Fluorescent dye staining with acridine orange and ethidium bromide showed that heptelidic acid inhibited apoptosis. Furthermore, it was found that DNA fragmentation and caspase-3 activation, the biological hallmarks of apoptosis, were inhibited by the compound in a dose-dependent manner, suggesting that heptelidic acid inhibits etoposide-induced apoptosis via downregulation of caspases.
AuthorsJin Hee Kim, Choong Hwan Lee
JournalJournal of microbiology and biotechnology (J Microbiol Biotechnol) Vol. 19 Issue 8 Pg. 787-91 (Aug 2009) ISSN: 1017-7825 [Print] Korea (South)
PMID19734716 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Caspase Inhibitors
  • Sesquiterpenes
  • heptelidic acid
  • Etoposide
  • Caspase 3
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (drug effects)
  • Caspase 3 (metabolism)
  • Caspase Inhibitors
  • DNA Fragmentation (drug effects)
  • Dose-Response Relationship, Drug
  • Etoposide (pharmacology)
  • Humans
  • Neurodegenerative Diseases (drug therapy, metabolism, physiopathology)
  • Sesquiterpenes (administration & dosage, chemistry, metabolism)
  • Trichoderma (chemistry, metabolism)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: